Rebiotix, Inc.

The microbiota-based MRT platform is a standardised, stabilised drug technology that is designed to rehabilitate the human microbiome by delivering a broad consortium of live microbes into a patient’s intestinal tract via ready-to-use and easy-to-administer formats.

Address
MN 55113
United States
Telephone

Microbiology Product Areas

Clinical

Clostridioides difficle Show all suppliers
Microbiome Show all suppliers